APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Prostate Cancer Drugs

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Prostate Cancer Drugs Market Analysis and Forecast 2026-2032

Report ID 174029370220 December 2025217 pages

Choose your research edition.

Industry ResearchProstate Cancer Drugs Industry Research Report 2026144 pages · $2,950 USDIndustry Growth & TrendsGlobal Prostate Cancer Drugs Industry Growth and Trends Forecast to 2032126 pages · $3,450 USDMarket StructureGlobal Prostate Cancer Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Prostate Cancer Drugs Market Outlook and Growth Opportunities 2026216 pages · $4,250 USDMarket Analysis & ForecastGlobal Prostate Cancer Drugs Market Analysis and Forecast 2026-2032217 pages · $4,950 USD

Market perspective

The global Prostate Cancer Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Prostate Cancer Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Prostate Cancer Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Prostate Cancer Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Prostate Cancer Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Prostate Cancer Drugs include Takeda Pharmaceuticals, Teva Pharmaceutical, Sanofi, Johnson & Johnson, Novartis, Merck Group, GlaxoSmithKline, Amgen and AbbVie, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Prostate Cancer Drugs, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Prostate Cancer Drugs, also provides the sales of main regions and countries. Of the upcoming market potential for Prostate Cancer Drugs, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Prostate Cancer Drugs sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Prostate Cancer Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Prostate Cancer Drugs sales, projected growth trends, production technology, application and end-user industry.

Prostate Cancer Drugs Segment by Company

Takeda Pharmaceuticals

Teva Pharmaceutical

Sanofi

Johnson & Johnson

Novartis

Merck Group

GlaxoSmithKline

Amgen

AbbVie

Tokai Pharmaceuticals

Spectrum Pharmaceuticals

Northwest Biotherapeutics

Janssen Pharmaceuticals

Foresee Pharmaceuticals

Ferring Pharmaceutical

Endo Pharmaceuticals

Boehringer Ingelheim

BMS

Bayer HealthCare

Astra Zeneca

Astellas Pharma

Prostate Cancer Drugs Segment by Type

Targeted Therapy

Chemotherapy

Hormonal Therapy

Immunotherapy

Prostate Cancer Drugs Segment by Application

Clinics

Hospitals

Others

Prostate Cancer Drugs Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Prostate Cancer Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Prostate Cancer Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Prostate Cancer Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Prostate Cancer Drugs in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Prostate Cancer Drugs manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Prostate Cancer Drugs sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Prostate Cancer Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Targeted Therapy Major Manufacturers Table 3. Chemotherapy Major Manufacturers Table 4. Hormonal Therapy Major Manufacturers Table 5. Immunotherapy Major Manufacturers Table 6. Global Prostate Cancer Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Clinics Major Manufacturers Table 8. Hospitals Major Manufacturers Table 9. Others Major Manufacturers Table 10. Prostate Cancer Drugs Industry Trends Table 11. Prostate Cancer Drugs Industry Drivers Table 12. Prostate Cancer Drugs Industry Opportunities and Challenges Table 13. Prostate Cancer Drugs Industry Restraints Table 14. Global Prostate Cancer Drugs Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 15. Global Prostate Cancer Drugs Revenue by Region (2021-2026) & (US$ Million) Table 16. Global Prostate Cancer Drugs Revenue by Region (2027-2032) & (US$ Million) Table 17. Global Prostate Cancer Drugs Revenue Market Share by Region (2021-2026) Table 18. Global Prostate Cancer Drugs Revenue Market Share by Region (2027-2032) Table 19. Global Prostate Cancer Drugs Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Tons) Table 20. Global Prostate Cancer Drugs Sales by Region (2021-2026) & (K Tons) Table 21. Global Prostate Cancer Drugs Sales by Region (2027-2032) & (K Tons) Table 22. Global Prostate Cancer Drugs Sales Market Share by Region (2021-2026) Table 23. Global Prostate Cancer Drugs Sales Market Share by Region (2027-2032) Table 24. Global Prostate Cancer Drugs Revenue by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Prostate Cancer Drugs Revenue Market Share by Manufacturers (2021-2026) Table 26. Global Prostate Cancer Drugs Sales by Manufacturers (US$ Million) & (2021-2026) Table 27. Global Prostate Cancer Drugs Sales Market Share by Manufacturers (2021-2026) Table 28. Global Prostate Cancer Drugs Sales Price (US$/Ton) of Manufacturers (2021-2026) Table 29. Global Prostate Cancer Drugs Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 30. Global Prostate Cancer Drugs Key Manufacturers Manufacturing Sites & Headquarters Table 31. Global Prostate Cancer Drugs Manufacturers, Product Type & Application Table 32. Global Prostate Cancer Drugs Manufacturers' Establishment Date Table 33. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 34. Global Prostate Cancer Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 35. Global Prostate Cancer Drugs Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Prostate Cancer Drugs Revenue by Type (2021-2026) & (US$ Million) Table 37. Global Prostate Cancer Drugs Revenue by Type (2027-2032) & (US$ Million) Table 38. Global Prostate Cancer Drugs Revenue Market Share by Type (2021-2026) Table 39. Global Prostate Cancer Drugs Revenue Market Share by Type (2027-2032) Table 40. Global Prostate Cancer Drugs Sales by Type 2021 VS 2025 VS 2032 (K Tons) Table 41. Global Prostate Cancer Drugs Sales by Type (2021-2026) & (K Tons) Table 42. Global Prostate Cancer Drugs Sales by Type (2027-2032) & (K Tons) Table 43. Global Prostate Cancer Drugs Sales Market Share by Type (2021-2026) Table 44. Global Prostate Cancer Drugs Sales Market Share by Type (2027-2032) Table 45. Global Prostate Cancer Drugs Price by Type (2021-2026) & (US$/Ton) Table 46. Global Prostate Cancer Drugs Price by Type (2027-2032) & (US$/Ton) Table 47. Global Prostate Cancer Drugs Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Prostate Cancer Drugs Revenue by Application (2021-2026) & (US$ Million) Table 49. Global Prostate Cancer Drugs Revenue by Application (2027-2032) & (US$ Million) Table 50. Global Prostate Cancer Drugs Revenue Market Share by Application (2021-2026) Table 51. Global Prostate Cancer Drugs Revenue Market Share by Application (2027-2032) Table 52. Global Prostate Cancer Drugs Sales by Application 2021 VS 2025 VS 2032 (K Tons) Table 53. Global Prostate Cancer Drugs Sales by Application (2021-2026) & (K Tons) Table 54. Global Prostate Cancer Drugs Sales by Application (2027-2032) & (K Tons) Table 55. Global Prostate Cancer Drugs Sales Market Share by Application (2021-2026) Table 56. Global Prostate Cancer Drugs Sales Market Share by Application (2027-2032) Table 57. Global Prostate Cancer Drugs Price by Application (2021-2026) & (US$/Ton) Table 58. Global Prostate Cancer Drugs Price by Application (2027-2032) & (US$/Ton) Table 59. Takeda Pharmaceuticals Company Information Table 60. Takeda Pharmaceuticals Business Overview Table 61. Takeda Pharmaceuticals Prostate Cancer Drugs Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 62. Takeda Pharmaceuticals Prostate Cancer Drugs Product Portfolio Table 63. Takeda Pharmaceuticals Recent Development Table 64. Teva Pharmaceutical Company Information Table 65. Teva Pharmaceutical Business Overview Table 66. Teva Pharmaceutical Prostate Cancer Drugs Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 67. Teva Pharmaceutical Prostate Cancer Drugs Product Portfolio Table 68. Teva Pharmaceutical Recent Development Table 69. Sanofi Company Information Table 70. Sanofi Business Overview Table 71. Sanofi Prostate Cancer Drugs Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 72. Sanofi Prostate Cancer Drugs Product Portfolio Table 73. Sanofi Recent Development Table 74. Johnson & Johnson Company Information Table 75. Johnson & Johnson Business Overview Table 76. Johnson & Johnson Prostate Cancer Drugs Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 77. Johnson & Johnson Prostate Cancer Drugs Product Portfolio Table 78. Johnson & Johnson Recent Development Table 79. Novartis Company Information Table 80. Novartis Business Overview Table 81. Novartis Prostate Cancer Drugs Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 82. Novartis Prostate Cancer Drugs Product Portfolio Table 83. Novartis Recent Development Table 84. Merck Group Company Information Table 85. Merck Group Business Overview Table 86. Merck Group Prostate Cancer Drugs Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 87. Merck Group Prostate Cancer Drugs Product Portfolio Table 88. Merck Group Recent Development Table 89. GlaxoSmithKline Company Information Table 90. GlaxoSmithKline Business Overview Table 91. GlaxoSmithKline Prostate Cancer Drugs Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 92. GlaxoSmithKline Prostate Cancer Drugs Product Portfolio Table 93. GlaxoSmithKline Recent Development Table 94. Amgen Company Information Table 95. Amgen Business Overview Table 96. Amgen Prostate Cancer Drugs Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 97. Amgen Prostate Cancer Drugs Product Portfolio Table 98. Amgen Recent Development Table 99. AbbVie Company Information Table 100. AbbVie Business Overview Table 101. AbbVie Prostate Cancer Drugs Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 102. AbbVie Prostate Cancer Drugs Product Portfolio Table 103. AbbVie Recent Development Table 104. Tokai Pharmaceuticals Company Information Table 105. Tokai Pharmaceuticals Business Overview Table 106. Tokai Pharmaceuticals Prostate Cancer Drugs Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 107. Tokai Pharmaceuticals Prostate Cancer Drugs Product Portfolio Table 108. Tokai Pharmaceuticals Recent Development Table 109. Spectrum Pharmaceuticals Company Information Table 110. Spectrum Pharmaceuticals Business Overview Table 111. Spectrum Pharmaceuticals Prostate Cancer Drugs Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 112. Spectrum Pharmaceuticals Prostate Cancer Drugs Product Portfolio Table 113. Spectrum Pharmaceuticals Recent Development Table 114. Northwest Biotherapeutics Company Information Table 115. Northwest Biotherapeutics Business Overview Table 116. Northwest Biotherapeutics Prostate Cancer Drugs Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 117. Northwest Biotherapeutics Prostate Cancer Drugs Product Portfolio Table 118. Northwest Biotherapeutics Recent Development Table 119. Janssen Pharmaceuticals Company Information Table 120. Janssen Pharmaceuticals Business Overview Table 121. Janssen Pharmaceuticals Prostate Cancer Drugs Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 122. Janssen Pharmaceuticals Prostate Cancer Drugs Product Portfolio Table 123. Janssen Pharmaceuticals Recent Development Table 124. Foresee Pharmaceuticals Company Information Table 125. Foresee Pharmaceuticals Business Overview Table 126. Foresee Pharmaceuticals Prostate Cancer Drugs Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 127. Foresee Pharmaceuticals Prostate Cancer Drugs Product Portfolio Table 128. Foresee Pharmaceuticals Recent Development Table 129. Ferring Pharmaceutical Company Information Table 130. Ferring Pharmaceutical Business Overview Table 131. Ferring Pharmaceutical Prostate Cancer Drugs Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 132. Ferring Pharmaceutical Prostate Cancer Drugs Product Portfolio Table 133. Ferring Pharmaceutical Recent Development Table 134. Endo Pharmaceuticals Company Information Table 135. Endo Pharmaceuticals Business Overview Table 136. Endo Pharmaceuticals Prostate Cancer Drugs Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 137. Endo Pharmaceuticals Prostate Cancer Drugs Product Portfolio Table 138. Endo Pharmaceuticals Recent Development Table 139. Boehringer Ingelheim Company Information Table 140. Boehringer Ingelheim Business Overview Table 141. Boehringer Ingelheim Prostate Cancer Drugs Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 142. Boehringer Ingelheim Prostate Cancer Drugs Product Portfolio Table 143. Boehringer Ingelheim Recent Development Table 144. BMS Company Information Table 145. BMS Business Overview Table 146. BMS Prostate Cancer Drugs Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 147. BMS Prostate Cancer Drugs Product Portfolio Table 148. BMS Recent Development Table 149. Bayer HealthCare Company Information Table 150. Bayer HealthCare Business Overview Table 151. Bayer HealthCare Prostate Cancer Drugs Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 152. Bayer HealthCare Prostate Cancer Drugs Product Portfolio Table 153. Bayer HealthCare Recent Development Table 154. Astra Zeneca Company Information Table 155. Astra Zeneca Business Overview Table 156. Astra Zeneca Prostate Cancer Drugs Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 157. Astra Zeneca Prostate Cancer Drugs Product Portfolio Table 158. Astra Zeneca Recent Development Table 159. Astellas Pharma Company Information Table 160. Astellas Pharma Business Overview Table 161. Astellas Pharma Prostate Cancer Drugs Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 162. Astellas Pharma Prostate Cancer Drugs Product Portfolio Table 163. Astellas Pharma Recent Development Table 164. North America Prostate Cancer Drugs Revenue by Type (2021-2026) & (US$ Million) Table 165. North America Prostate Cancer Drugs Revenue by Type (2027-2032) & (US$ Million) Table 166. North America Prostate Cancer Drugs Sales by Type (2021-2026) & (K Tons) Table 167. North America Prostate Cancer Drugs Sales by Type (2027-2032) & (K Tons) Table 168. North America Prostate Cancer Drugs Sales Price by Type (2021-2026) & (US$/Ton) Table 169. North America Prostate Cancer Drugs Sales Price by Type (2027-2032) & (US$/Ton) Table 170. North America Prostate Cancer Drugs Revenue by Application (2021-2026) & (US$ Million) Table 171. North America Prostate Cancer Drugs Revenue by Application (2027-2032) & (US$ Million) Table 172. North America Prostate Cancer Drugs Sales by Application (2021-2026) & (K Tons) Table 173. North America Prostate Cancer Drugs Sales by Application (2027-2032) & (K Tons) Table 174. North America Prostate Cancer Drugs Sales Price by Application (2021-2026) & (US$/Ton) Table 175. North America Prostate Cancer Drugs Sales Price by Application (2027-2032) & (US$/Ton) Table 176. North America Prostate Cancer Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 177. North America Prostate Cancer Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 178. North America Prostate Cancer Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 179. North America Prostate Cancer Drugs Sales by Country (2021 VS 2025 VS 2032) & (K Tons) Table 180. North America Prostate Cancer Drugs Sales by Country (2021-2026) & (K Tons) Table 181. North America Prostate Cancer Drugs Sales by Country (2027-2032) & (K Tons) Table 182. North America Prostate Cancer Drugs Sales Price by Country (2021-2026) & (US$/Ton) Table 183. North America Prostate Cancer Drugs Sales Price by Country (2027-2032) & (US$/Ton) Table 184. United States Prostate Cancer Drugs Revenue (2021-2032) & (US$ Million) Table 185. Canada Prostate Cancer Drugs Revenue (2021-2032) & (US$ Million) Table 186. Europe Prostate Cancer Drugs Revenue by Type (2021-2026) & (US$ Million) Table 187. Europe Prostate Cancer Drugs Revenue by Type (2027-2032) & (US$ Million) Table 188. Europe Prostate Cancer Drugs Sales by Type (2021-2026) & (K Tons) Table 189. Europe Prostate Cancer Drugs Sales by Type (2027-2032) & (K Tons) Table 190. Europe Prostate Cancer Drugs Sales Price by Type (2021-2026) & (US$/Ton) Table 191. Europe Prostate Cancer Drugs Sales Price by Type (2027-2032) & (US$/Ton) Table 192. Europe Prostate Cancer Drugs Revenue by Application (2021-2026) & (US$ Million) Table 193. Europe Prostate Cancer Drugs Revenue by Application (2027-2032) & (US$ Million) Table 194. Europe Prostate Cancer Drugs Sales by Application (2021-2026) & (K Tons) Table 195. Europe Prostate Cancer Drugs Sales by Application (2027-2032) & (K Tons) Table 196. Europe Prostate Cancer Drugs Sales Price by Application (2021-2026) & (US$/Ton) Table 197. Europe Prostate Cancer Drugs Sales Price by Application (2027-2032) & (US$/Ton) Table 198. Europe Prostate Cancer Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 199. Europe Prostate Cancer Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 200. Europe Prostate Cancer Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 201. Europe Prostate Cancer Drugs Sales by Country (2021 VS 2025 VS 2032) & (K Tons) Table 202. Europe Prostate Cancer Drugs Sales by Country (2021-2026) & (K Tons) Table 203. Europe Prostate Cancer Drugs Sales by Country (2027-2032) & (K Tons) Table 204. Europe Prostate Cancer Drugs Sales Price by Country (2021-2026) & (US$/Ton) Table 205. Europe Prostate Cancer Drugs Sales Price by Country (2027-2032) & (US$/Ton) Table 206. Germany Prostate Cancer Drugs Revenue (2021-2032) & (US$ Million) Table 207. France Prostate Cancer Drugs Revenue (2021-2032) & (US$ Million) Table 208. U.K. Prostate Cancer Drugs Revenue (2021-2032) & (US$ Million) Table 209. Italy Prostate Cancer Drugs Revenue (2021-2032) & (US$ Million) Table 210. Netherlands Prostate Cancer Drugs Revenue (2021-2032) & (US$ Million) Table 211. Nordic Countries Prostate Cancer Drugs Revenue (2021-2032) & (US$ Million) Table 212. China Prostate Cancer Drugs Revenue by Type (2021-2026) & (US$ Million) Table 213. China Prostate Cancer Drugs Revenue by Type (2027-2032) & (US$ Million) Table 214. China Prostate Cancer Drugs Sales by Type (2021-2026) & (K Tons) Table 215. China Prostate Cancer Drugs Sales by Type (2027-2032) & (K Tons) Table 216. China Prostate Cancer Drugs Sales Price by Type (2021-2026) & (US$/Ton) Table 217. China Prostate Cancer Drugs Sales Price by Type (2027-2032) & (US$/Ton) Table 218. China Prostate Cancer Drugs Revenue by Application (2021-2026) & (US$ Million) Table 219. China Prostate Cancer Drugs Revenue by Application (2027-2032) & (US$ Million) Table 220. China Prostate Cancer Drugs Sales by Application (2021-2026) & (K Tons) Table 221. China Prostate Cancer Drugs Sales by Application (2027-2032) & (K Tons) Table 222. China Prostate Cancer Drugs Sales Price by Application (2021-2026) & (US$/Ton) Table 223. China Prostate Cancer Drugs Sales Price by Application (2027-2032) & (US$/Ton) Table 224. Asia Prostate Cancer Drugs Revenue by Type (2021-2026) & (US$ Million) Table 225. Asia Prostate Cancer Drugs Revenue by Type (2027-2032) & (US$ Million) Table 226. Asia Prostate Cancer Drugs Sales by Type (2021-2026) & (K Tons) Table 227. Asia Prostate Cancer Drugs Sales by Type (2027-2032) & (K Tons) Table 228. Asia Prostate Cancer Drugs Sales Price by Type (2021-2026) & (US$/Ton) Table 229. Asia Prostate Cancer Drugs Sales Price by Type (2027-2032) & (US$/Ton) Table 230. Asia Prostate Cancer Drugs Revenue by Application (2021-2026) & (US$ Million) Table 231. Asia Prostate Cancer Drugs Revenue by Application (2027-2032) & (US$ Million) Table 232. Asia Prostate Cancer Drugs Sales by Application (2021-2026) & (K Tons) Table 233. Asia Prostate Cancer Drugs Sales by Application (2027-2032) & (K Tons) Table 234. Asia Prostate Cancer Drugs Sales Price by Application (2021-2026) & (US$/Ton) Table 235. Asia Prostate Cancer Drugs Sales Price by Application (2027-2032) & (US$/Ton) Table 236. Asia Prostate Cancer Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 237. Asia Prostate Cancer Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 238. Asia Prostate Cancer Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 239. Asia Prostate Cancer Drugs Sales by Country (2021 VS 2025 VS 2032) & (K Tons) Table 240. Asia Prostate Cancer Drugs Sales by Country (2021-2026) & (K Tons) Table 241. Asia Prostate Cancer Drugs Sales by Country (2027-2032) & (K Tons) Table 242. Asia Prostate Cancer Drugs Sales Price by Country (2021-2026) & (US$/Ton) Table 243. Asia Prostate Cancer Drugs Sales Price by Country (2027-2032) & (US$/Ton) Table 244. Japan Prostate Cancer Drugs Revenue (2021-2032) & (US$ Million) Table 245. South Korea Prostate Cancer Drugs Revenue (2021-2032) & (US$ Million) Table 246. India Prostate Cancer Drugs Revenue (2021-2032) & (US$ Million) Table 247. Australia Prostate Cancer Drugs Revenue (2021-2032) & (US$ Million) Table 248. China Taiwan Prostate Cancer Drugs Revenue (2021-2032) & (US$ Million) Table 249. Southeast Asia Prostate Cancer Drugs Revenue (2021-2032) & (US$ Million) Table 250. SAMEA Prostate Cancer Drugs Revenue by Type (2021-2026) & (US$ Million) Table 251. SAMEA Prostate Cancer Drugs Revenue by Type (2027-2032) & (US$ Million) Table 252. SAMEA Prostate Cancer Drugs Sales by Type (2021-2026) & (K Tons) Table 253. SAMEA Prostate Cancer Drugs Sales by Type (2027-2032) & (K Tons) Table 254. SAMEA Prostate Cancer Drugs Sales Price by Type (2021-2026) & (US$/Ton) Table 255. SAMEA Prostate Cancer Drugs Sales Price by Type (2027-2032) & (US$/Ton) Table 256. SAMEA Prostate Cancer Drugs Revenue by Application (2021-2026) & (US$ Million) Table 257. SAMEA Prostate Cancer Drugs Revenue by Application (2027-2032) & (US$ Million) Table 258. SAMEA Prostate Cancer Drugs Sales by Application (2021-2026) & (K Tons) Table 259. SAMEA Prostate Cancer Drugs Sales by Application (2027-2032) & (K Tons) Table 260. SAMEA Prostate Cancer Drugs Sales Price by Application (2021-2026) & (US$/Ton) Table 261. SAMEA Prostate Cancer Drugs Sales Price by Application (2027-2032) & (US$/Ton) Table 262. SAMEA Prostate Cancer Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 263. SAMEA Prostate Cancer Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 264. SAMEA Prostate Cancer Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 265. SAMEA Prostate Cancer Drugs Sales by Country (2021 VS 2025 VS 2032) & (K Tons) Table 266. SAMEA Prostate Cancer Drugs Sales by Country (2021-2026) & (K Tons) Table 267. SAMEA Prostate Cancer Drugs Sales by Country (2027-2032) & (K Tons) Table 268. SAMEA Prostate Cancer Drugs Sales Price by Country (2021-2026) & (US$/Ton) Table 269. SAMEA Prostate Cancer Drugs Sales Price by Country (2027-2032) & (US$/Ton) Table 270. Brazil Prostate Cancer Drugs Revenue (2021-2032) & (US$ Million) Table 271. Argentina Prostate Cancer Drugs Revenue (2021-2032) & (US$ Million) Table 272. Chile Prostate Cancer Drugs Revenue (2021-2032) & (US$ Million) Table 273. Colombia Prostate Cancer Drugs Revenue (2021-2032) & (US$ Million) Table 274. Peru Prostate Cancer Drugs Revenue (2021-2032) & (US$ Million) Table 275. Saudi Arabia Prostate Cancer Drugs Revenue (2021-2032) & (US$ Million) Table 276. Israel Prostate Cancer Drugs Revenue (2021-2032) & (US$ Million) Table 277. UAE Prostate Cancer Drugs Revenue (2021-2032) & (US$ Million) Table 278. Turkey Prostate Cancer Drugs Revenue (2021-2032) & (US$ Million) Table 279. Iran Prostate Cancer Drugs Revenue (2021-2032) & (US$ Million) Table 280. Egypt Prostate Cancer Drugs Revenue (2021-2032) & (US$ Million) Table 281. Key Raw Materials Table 282. Raw Materials Key Suppliers Table 283. Prostate Cancer Drugs Distributors List Table 284. Prostate Cancer Drugs Customers List Table 285. Research Programs/Design for This Report Table 286. Authors List of This Report Table 287. Secondary Sources Table 288. Primary Sources List of Figures Figure 1. Prostate Cancer Drugs Image Figure 2. Global Prostate Cancer Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Prostate Cancer Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 4. Targeted Therapy Image Figure 5. Chemotherapy Image Figure 6. Hormonal Therapy Image Figure 7. Immunotherapy Image Figure 8. Global Prostate Cancer Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Prostate Cancer Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 10. Clinics Image Figure 11. Hospitals Image Figure 12. Others Image Figure 13. Global Prostate Cancer Drugs Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Prostate Cancer Drugs Revenue (2021-2032) & (US$ Million) Figure 15. Global Prostate Cancer Drugs Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 16. Global Prostate Cancer Drugs Revenue Market Share by Region: 2025 Versus 2032 Figure 17. Global Prostate Cancer Drugs Revenue Market Share by Region (2021-2032) Figure 18. Global Prostate Cancer Drugs Sales (2021-2032) & (K Tons) Figure 19. Global Prostate Cancer Drugs Sales by Region: 2021 VS 2025 VS 2032 (K Tons) Figure 20. Global Prostate Cancer Drugs Sales Market Share by Region (2021-2032) Figure 21. US & Canada & Mexico Prostate Cancer Drugs Sales YoY (2021-2032) & (K Tons) Figure 22. Europe Prostate Cancer Drugs Sales YoY (2021-2032) & (K Tons) Figure 23. China Prostate Cancer Drugs Sales YoY (2021-2032) & (K Tons) Figure 24. Asia (Excluding China) Prostate Cancer Drugs Sales YoY (2021-2032) & (K Tons) Figure 25. South America, Middle East and Africa Prostate Cancer Drugs Sales YoY (2021-2032) & (K Tons) Figure 26. Global Prostate Cancer Drugs Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 27. Global Prostate Cancer Drugs Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 28. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Global Prostate Cancer Drugs Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 30. Global Prostate Cancer Drugs Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Prostate Cancer Drugs Revenue Market Share by Type (2021-2032) Figure 32. Global Prostate Cancer Drugs Sales by Type (2021 VS 2025 VS 2032) & (K Tons) Figure 33. Global Prostate Cancer Drugs Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 34. Global Prostate Cancer Drugs Sales Market Share by Type (2021-2032) Figure 35. Global Prostate Cancer Drugs Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 36. Global Prostate Cancer Drugs Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Prostate Cancer Drugs Revenue Market Share by Application (2021-2032) Figure 38. Global Prostate Cancer Drugs Sales by Application (2021 VS 2025 VS 2032) & (K Tons) Figure 39. Global Prostate Cancer Drugs Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 40. Global Prostate Cancer Drugs Sales Market Share by Application (2021-2032) Figure 41. North America Prostate Cancer Drugs Revenue Share by Type (2021-2032) Figure 42. North America Prostate Cancer Drugs Sales Share by Type (2021-2032) Figure 43. North America Prostate Cancer Drugs Revenue Share by Application (2021-2032) Figure 44. North America Prostate Cancer Drugs Sales Share by Application (2021-2032) Figure 45. North America Prostate Cancer Drugs Revenue Share by Country (2021-2032) Figure 46. North America Prostate Cancer Drugs Sales Share by Country (2021-2032) Figure 47. Europe Prostate Cancer Drugs Revenue Share by Type (2021-2032) Figure 48. Europe Prostate Cancer Drugs Sales Share by Type (2021-2032) Figure 49. Europe Prostate Cancer Drugs Revenue Share by Application (2021-2032) Figure 50. Europe Prostate Cancer Drugs Sales Share by Application (2021-2032) Figure 51. Europe Prostate Cancer Drugs Revenue Share by Country (2021-2032) Figure 52. Europe Prostate Cancer Drugs Sales Share by Country (2021-2032) Figure 53. China Prostate Cancer Drugs Revenue Share by Type (2021-2032) Figure 54. China Prostate Cancer Drugs Sales Share by Type (2021-2032) Figure 55. China Prostate Cancer Drugs Revenue Share by Application (2021-2032) Figure 56. China Prostate Cancer Drugs Sales Share by Application (2021-2032) Figure 57. Asia Prostate Cancer Drugs Revenue Share by Type (2021-2032) Figure 58. Asia Prostate Cancer Drugs Sales Share by Type (2021-2032) Figure 59. Asia Prostate Cancer Drugs Revenue Share by Application (2021-2032) Figure 60. Asia Prostate Cancer Drugs Sales Share by Application (2021-2032) Figure 61. Asia Prostate Cancer Drugs Revenue Share by Country (2021-2032) Figure 62. Asia Prostate Cancer Drugs Sales Share by Country (2021-2032) Figure 63. SAMEA Prostate Cancer Drugs Revenue Share by Type (2021-2032) Figure 64. SAMEA Prostate Cancer Drugs Sales Share by Type (2021-2032) Figure 65. SAMEA Prostate Cancer Drugs Revenue Share by Application (2021-2032) Figure 66. SAMEA Prostate Cancer Drugs Sales Share by Application (2021-2032) Figure 67. SAMEA Prostate Cancer Drugs Revenue Share by Country (2021-2032) Figure 68. SAMEA Prostate Cancer Drugs Sales Share by Country (2021-2032) Figure 69. Prostate Cancer Drugs Value Chain Figure 70. Manufacturing Cost Structure Figure 71. Prostate Cancer Drugs Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • Targeted Therapy
  • Chemotherapy
  • Hormonal Therapy
  • Immunotherapy
Applications
  • Clinics
  • Hospitals
  • Others
Companies covered
  • Takeda Pharmaceuticals
  • Teva Pharmaceutical
  • Sanofi
  • Johnson & Johnson
  • Novartis
  • Merck Group
  • GlaxoSmithKline
  • Amgen
  • AbbVie
  • Tokai Pharmaceuticals
  • Spectrum Pharmaceuticals
  • Northwest Biotherapeutics
  • Janssen Pharmaceuticals
  • Foresee Pharmaceuticals
  • Ferring Pharmaceutical
  • Endo Pharmaceuticals
  • Boehringer Ingelheim
  • BMS
  • Bayer HealthCare
  • Astra Zeneca
  • Astellas Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Prostate Cancer Drugs Market by Type
  3. 1.2.1 Global Prostate Cancer Drugs Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Targeted Therapy
  5. 1.2.3 Chemotherapy
  6. 1.2.4 Hormonal Therapy
  7. 1.2.5 Immunotherapy
  8. 1.3 Prostate Cancer Drugs Market by Application
  9. 1.3.1 Global Prostate Cancer Drugs Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Clinics
  11. 1.3.3 Hospitals
  12. 1.3.4 Others
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Prostate Cancer Drugs Market Dynamics
  1. 2.1 Prostate Cancer Drugs Industry Trends
  2. 2.2 Prostate Cancer Drugs Industry Drivers
  3. 2.3 Prostate Cancer Drugs Industry Opportunities and Challenges
  4. 2.4 Prostate Cancer Drugs Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Prostate Cancer Drugs Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Prostate Cancer Drugs Revenue by Region
  3. 3.2.1 Global Prostate Cancer Drugs Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Prostate Cancer Drugs Revenue by Region (2021-2026)
  5. 3.2.3 Global Prostate Cancer Drugs Revenue by Region (2027-2032)
  6. 3.2.4 Global Prostate Cancer Drugs Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Prostate Cancer Drugs Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Prostate Cancer Drugs Sales by Region
  9. 3.4.1 Global Prostate Cancer Drugs Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Prostate Cancer Drugs Sales by Region (2021-2026)
  11. 3.4.3 Global Prostate Cancer Drugs Sales by Region (2027-2032)
  12. 3.4.4 Global Prostate Cancer Drugs Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Prostate Cancer Drugs Revenue by Manufacturers
  2. 4.1.1 Global Prostate Cancer Drugs Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Prostate Cancer Drugs Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Prostate Cancer Drugs Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Prostate Cancer Drugs Sales by Manufacturers
  6. 4.2.1 Global Prostate Cancer Drugs Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Prostate Cancer Drugs Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Prostate Cancer Drugs Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Prostate Cancer Drugs Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Prostate Cancer Drugs Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Prostate Cancer Drugs Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Prostate Cancer Drugs Manufacturers, Product Type & Application
  13. 4.7 Global Prostate Cancer Drugs Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Prostate Cancer Drugs Market CR5 and HHI
  16. 4.8.2 2025 Prostate Cancer Drugs Tier 1, Tier 2, and Tier 3
5 Prostate Cancer Drugs Market by Type
  1. 5.1 Global Prostate Cancer Drugs Revenue by Type
  2. 5.1.1 Global Prostate Cancer Drugs Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Prostate Cancer Drugs Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Prostate Cancer Drugs Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Prostate Cancer Drugs Sales by Type
  6. 5.2.1 Global Prostate Cancer Drugs Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Prostate Cancer Drugs Sales by Type (2021-2032) & (K Tons)
  8. 5.2.3 Global Prostate Cancer Drugs Sales Market Share by Type (2021-2032)
  9. 5.3 Global Prostate Cancer Drugs Price by Type
6 Prostate Cancer Drugs Market by Application
  1. 6.1 Global Prostate Cancer Drugs Revenue by Application
  2. 6.1.1 Global Prostate Cancer Drugs Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Prostate Cancer Drugs Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Prostate Cancer Drugs Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Prostate Cancer Drugs Sales by Application
  6. 6.2.1 Global Prostate Cancer Drugs Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Prostate Cancer Drugs Sales by Application (2021-2032) & (K Tons)
  8. 6.2.3 Global Prostate Cancer Drugs Sales Market Share by Application (2021-2032)
  9. 6.3 Global Prostate Cancer Drugs Price by Application
7 Company Profiles
  1. 7.1 Takeda Pharmaceuticals
  2. 7.1.1 Takeda Pharmaceuticals Company Information
  3. 7.1.2 Takeda Pharmaceuticals Business Overview
  4. 7.1.3 Takeda Pharmaceuticals Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Takeda Pharmaceuticals Prostate Cancer Drugs Product Portfolio
  6. 7.1.5 Takeda Pharmaceuticals Recent Developments
  7. 7.2 Teva Pharmaceutical
  8. 7.2.1 Teva Pharmaceutical Company Information
  9. 7.2.2 Teva Pharmaceutical Business Overview
  10. 7.2.3 Teva Pharmaceutical Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Teva Pharmaceutical Prostate Cancer Drugs Product Portfolio
  12. 7.2.5 Teva Pharmaceutical Recent Developments
  13. 7.3 Sanofi
  14. 7.3.1 Sanofi Company Information
  15. 7.3.2 Sanofi Business Overview
  16. 7.3.3 Sanofi Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Sanofi Prostate Cancer Drugs Product Portfolio
  18. 7.3.5 Sanofi Recent Developments
  19. 7.4 Johnson & Johnson
  20. 7.4.1 Johnson & Johnson Company Information
  21. 7.4.2 Johnson & Johnson Business Overview
  22. 7.4.3 Johnson & Johnson Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Johnson & Johnson Prostate Cancer Drugs Product Portfolio
  24. 7.4.5 Johnson & Johnson Recent Developments
  25. 7.5 Novartis
  26. 7.5.1 Novartis Company Information
  27. 7.5.2 Novartis Business Overview
  28. 7.5.3 Novartis Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Novartis Prostate Cancer Drugs Product Portfolio
  30. 7.5.5 Novartis Recent Developments
  31. 7.6 Merck Group
  32. 7.6.1 Merck Group Company Information
  33. 7.6.2 Merck Group Business Overview
  34. 7.6.3 Merck Group Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Merck Group Prostate Cancer Drugs Product Portfolio
  36. 7.6.5 Merck Group Recent Developments
  37. 7.7 GlaxoSmithKline
  38. 7.7.1 GlaxoSmithKline Company Information
  39. 7.7.2 GlaxoSmithKline Business Overview
  40. 7.7.3 GlaxoSmithKline Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 GlaxoSmithKline Prostate Cancer Drugs Product Portfolio
  42. 7.7.5 GlaxoSmithKline Recent Developments
  43. 7.8 Amgen
  44. 7.8.1 Amgen Company Information
  45. 7.8.2 Amgen Business Overview
  46. 7.8.3 Amgen Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Amgen Prostate Cancer Drugs Product Portfolio
  48. 7.8.5 Amgen Recent Developments
  49. 7.9 AbbVie
  50. 7.9.1 AbbVie Company Information
  51. 7.9.2 AbbVie Business Overview
  52. 7.9.3 AbbVie Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 AbbVie Prostate Cancer Drugs Product Portfolio
  54. 7.9.5 AbbVie Recent Developments
  55. 7.10 Tokai Pharmaceuticals
  56. 7.10.1 Tokai Pharmaceuticals Company Information
  57. 7.10.2 Tokai Pharmaceuticals Business Overview
  58. 7.10.3 Tokai Pharmaceuticals Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Tokai Pharmaceuticals Prostate Cancer Drugs Product Portfolio
  60. 7.10.5 Tokai Pharmaceuticals Recent Developments
  61. 7.11 Spectrum Pharmaceuticals
  62. 7.11.1 Spectrum Pharmaceuticals Company Information
  63. 7.11.2 Spectrum Pharmaceuticals Business Overview
  64. 7.11.3 Spectrum Pharmaceuticals Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Spectrum Pharmaceuticals Prostate Cancer Drugs Product Portfolio
  66. 7.11.5 Spectrum Pharmaceuticals Recent Developments
  67. 7.12 Northwest Biotherapeutics
  68. 7.12.1 Northwest Biotherapeutics Company Information
  69. 7.12.2 Northwest Biotherapeutics Business Overview
  70. 7.12.3 Northwest Biotherapeutics Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Northwest Biotherapeutics Prostate Cancer Drugs Product Portfolio
  72. 7.12.5 Northwest Biotherapeutics Recent Developments
  73. 7.13 Janssen Pharmaceuticals
  74. 7.13.1 Janssen Pharmaceuticals Company Information
  75. 7.13.2 Janssen Pharmaceuticals Business Overview
  76. 7.13.3 Janssen Pharmaceuticals Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Janssen Pharmaceuticals Prostate Cancer Drugs Product Portfolio
  78. 7.13.5 Janssen Pharmaceuticals Recent Developments
  79. 7.14 Foresee Pharmaceuticals
  80. 7.14.1 Foresee Pharmaceuticals Company Information
  81. 7.14.2 Foresee Pharmaceuticals Business Overview
  82. 7.14.3 Foresee Pharmaceuticals Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Foresee Pharmaceuticals Prostate Cancer Drugs Product Portfolio
  84. 7.14.5 Foresee Pharmaceuticals Recent Developments
  85. 7.15 Ferring Pharmaceutical
  86. 7.15.1 Ferring Pharmaceutical Company Information
  87. 7.15.2 Ferring Pharmaceutical Business Overview
  88. 7.15.3 Ferring Pharmaceutical Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Ferring Pharmaceutical Prostate Cancer Drugs Product Portfolio
  90. 7.15.5 Ferring Pharmaceutical Recent Developments
  91. 7.16 Endo Pharmaceuticals
  92. 7.16.1 Endo Pharmaceuticals Company Information
  93. 7.16.2 Endo Pharmaceuticals Business Overview
  94. 7.16.3 Endo Pharmaceuticals Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 Endo Pharmaceuticals Prostate Cancer Drugs Product Portfolio
  96. 7.16.5 Endo Pharmaceuticals Recent Developments
  97. 7.17 Boehringer Ingelheim
  98. 7.17.1 Boehringer Ingelheim Company Information
  99. 7.17.2 Boehringer Ingelheim Business Overview
  100. 7.17.3 Boehringer Ingelheim Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  101. 7.17.4 Boehringer Ingelheim Prostate Cancer Drugs Product Portfolio
  102. 7.17.5 Boehringer Ingelheim Recent Developments
  103. 7.18 BMS
  104. 7.18.1 BMS Company Information
  105. 7.18.2 BMS Business Overview
  106. 7.18.3 BMS Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  107. 7.18.4 BMS Prostate Cancer Drugs Product Portfolio
  108. 7.18.5 BMS Recent Developments
  109. 7.19 Bayer HealthCare
  110. 7.19.1 Bayer HealthCare Company Information
  111. 7.19.2 Bayer HealthCare Business Overview
  112. 7.19.3 Bayer HealthCare Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  113. 7.19.4 Bayer HealthCare Prostate Cancer Drugs Product Portfolio
  114. 7.19.5 Bayer HealthCare Recent Developments
  115. 7.20 Astra Zeneca
  116. 7.20.1 Astra Zeneca Company Information
  117. 7.20.2 Astra Zeneca Business Overview
  118. 7.20.3 Astra Zeneca Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  119. 7.20.4 Astra Zeneca Prostate Cancer Drugs Product Portfolio
  120. 7.20.5 Astra Zeneca Recent Developments
  121. 7.21 Astellas Pharma
  122. 7.21.1 Astellas Pharma Company Information
  123. 7.21.2 Astellas Pharma Business Overview
  124. 7.21.3 Astellas Pharma Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  125. 7.21.4 Astellas Pharma Prostate Cancer Drugs Product Portfolio
  126. 7.21.5 Astellas Pharma Recent Developments
8 North America
  1. 8.1 North America Prostate Cancer Drugs Market Size by Type
  2. 8.1.1 North America Prostate Cancer Drugs Revenue by Type (2021-2032)
  3. 8.1.2 North America Prostate Cancer Drugs Sales by Type (2021-2032)
  4. 8.1.3 North America Prostate Cancer Drugs Price by Type (2021-2032)
  5. 8.2 North America Prostate Cancer Drugs Market Size by Application
  6. 8.2.1 North America Prostate Cancer Drugs Revenue by Application (2021-2032)
  7. 8.2.2 North America Prostate Cancer Drugs Sales by Application (2021-2032)
  8. 8.2.3 North America Prostate Cancer Drugs Price by Application (2021-2032)
  9. 8.3 North America Prostate Cancer Drugs Market Size by Country
  10. 8.3.1 North America Prostate Cancer Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Prostate Cancer Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Prostate Cancer Drugs Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Prostate Cancer Drugs Market Size by Type
  2. 9.1.1 Europe Prostate Cancer Drugs Revenue by Type (2021-2032)
  3. 9.1.2 Europe Prostate Cancer Drugs Sales by Type (2021-2032)
  4. 9.1.3 Europe Prostate Cancer Drugs Price by Type (2021-2032)
  5. 9.2 Europe Prostate Cancer Drugs Market Size by Application
  6. 9.2.1 Europe Prostate Cancer Drugs Revenue by Application (2021-2032)
  7. 9.2.2 Europe Prostate Cancer Drugs Sales by Application (2021-2032)
  8. 9.2.3 Europe Prostate Cancer Drugs Price by Application (2021-2032)
  9. 9.3 Europe Prostate Cancer Drugs Market Size by Country
  10. 9.3.1 Europe Prostate Cancer Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Prostate Cancer Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Prostate Cancer Drugs Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
  18. 9.3.9 Nordic Countries
10 China
  1. 10.1 China Prostate Cancer Drugs Market Size by Type
  2. 10.1.1 China Prostate Cancer Drugs Revenue by Type (2021-2032)
  3. 10.1.2 China Prostate Cancer Drugs Sales by Type (2021-2032)
  4. 10.1.3 China Prostate Cancer Drugs Price by Type (2021-2032)
  5. 10.2 China Prostate Cancer Drugs Market Size by Application
  6. 10.2.1 China Prostate Cancer Drugs Revenue by Application (2021-2032)
  7. 10.2.2 China Prostate Cancer Drugs Sales by Application (2021-2032)
  8. 10.2.3 China Prostate Cancer Drugs Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Prostate Cancer Drugs Market Size by Type
  2. 11.1.1 Asia Prostate Cancer Drugs Revenue by Type (2021-2032)
  3. 11.1.2 Asia Prostate Cancer Drugs Sales by Type (2021-2032)
  4. 11.1.3 Asia Prostate Cancer Drugs Price by Type (2021-2032)
  5. 11.2 Asia Prostate Cancer Drugs Market Size by Application
  6. 11.2.1 Asia Prostate Cancer Drugs Revenue by Application (2021-2032)
  7. 11.2.2 Asia Prostate Cancer Drugs Sales by Application (2021-2032)
  8. 11.2.3 Asia Prostate Cancer Drugs Price by Application (2021-2032)
  9. 11.3 Asia Prostate Cancer Drugs Market Size by Country
  10. 11.3.1 Asia Prostate Cancer Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Prostate Cancer Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Prostate Cancer Drugs Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Prostate Cancer Drugs Market Size by Type
  2. 12.1.1 SAMEA Prostate Cancer Drugs Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Prostate Cancer Drugs Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Prostate Cancer Drugs Price by Type (2021-2032)
  5. 12.2 SAMEA Prostate Cancer Drugs Market Size by Application
  6. 12.2.1 SAMEA Prostate Cancer Drugs Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Prostate Cancer Drugs Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Prostate Cancer Drugs Price by Application (2021-2032)
  9. 12.3 SAMEA Prostate Cancer Drugs Market Size by Country
  10. 12.3.1 SAMEA Prostate Cancer Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Prostate Cancer Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Prostate Cancer Drugs Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Prostate Cancer Drugs Value Chain Analysis
  2. 13.1.1 Prostate Cancer Drugs Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Prostate Cancer Drugs Production Mode & Process
  6. 13.2 Prostate Cancer Drugs Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Prostate Cancer Drugs Distributors
  9. 13.2.3 Prostate Cancer Drugs Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst